Argenica Therapeutics Limited (ASX:AGN)
Australia · Delayed Price · Currency is AUD 0.1200
+0.0100 (9.09%)
May 29, 2026, 4:10 PM AEST
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 15.41 million as of May 29, 2026. Its market cap has decreased by -83.95% in one year.
Market Cap
15.41M
Enterprise Value
10.38M
Revenue
1.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has decreased from 19.02M to 15.41M, a decrease of -18.98%. That is a compound annual growth rate of -4.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 15.41M | -59.32% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
| Jun 11, 2021 | 19.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Patrys | 30.00M |
| EZZ Life Science Holdings | 29.75M |
| Noxopharm | 26.42M |
| Algorae Pharmaceuticals | 23.27M |
| Proteomics International Laboratories | 22.30M |
| Neurotech International | 15.81M |
| Immuron | 13.07M |
| AdAlta | 11.95M |